Kexing Biopharm Co., Ltd.SSE: 688136

Announcement on Voluntary Disclosure of GB19 Injection Obtaining FDA Clinical Trial Approval for New Drugs

· Issued by Kexing Biopharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-voluntary-disclosure-of-gb19-injection-obtaining-fda-clinical-trial-approval-for-new-drugs

Release

Announcement on Voluntary Disclosure of GB19 Injection Obtaining FDA Clinical Trial Approval for New Drugs

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Kexing Biopharm Co., Ltd. on 6ix

Earlier from Kexing Biopharm

Later from Kexing Biopharm

All Kexing Biopharm news releases